Other clinical scoring systems, such as the aMAP score (based on age, sex, albumin, bilirubin, and platelets) and the Doylestown algorithm (including age, sex, AFP, alanine transaminase [ALT], and alkaline phosphatase [ALP]), provide additional approaches to HCC risk stratification [15,16]. Here, GPT is linked to hepatocellular carcinoma.